Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Capital Employed (2020 - 2025)

Revolution Medicines has reported Return on Capital Employed over the past 6 years, most recently at 0.12% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.12% for Q4 2025, up 23.0% from a year ago — trailing twelve months through Dec 2025 was 0.12% (up 23.0% YoY), and the annual figure for FY2025 was 0.11%, up 21.0%.
  • Return on Capital Employed for Q4 2025 was 0.12% at Revolution Medicines, up from 0.49% in the prior quarter.
  • Over the last five years, Return on Capital Employed for RVMD hit a ceiling of 0.12% in Q4 2025 and a floor of 0.49% in Q3 2025.
  • Median Return on Capital Employed over the past 5 years was 0.34% (2024), compared with a mean of 0.32%.
  • Biggest five-year swings in Return on Capital Employed: dropped -19bps in 2022 and later rose 23bps in 2025.
  • Revolution Medicines' Return on Capital Employed stood at 0.28% in 2021, then dropped by -23bps to 0.34% in 2022, then decreased by -4bps to 0.35% in 2023, then grew by 2bps to 0.35% in 2024, then skyrocketed by 66bps to 0.12% in 2025.
  • The last three reported values for Return on Capital Employed were 0.12% (Q4 2025), 0.49% (Q3 2025), and 0.41% (Q2 2025) per Business Quant data.